Botulinum toxin in the management of acquired motor fusion deficiency.
Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption which was managed successfully with botulinum toxin injection.
Department of Pediatric Ophthalmology and Strabismus, and Oculoplasty, Orbital diseases and Ocular Oncology, LV Prasad Eye Institute, Hyderabad, India. drrameshmurthy@gmail.com
Ramesh
R
Murthy
Siddharth
S
Kesarwani
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D003867:Depth Perception / Q000502:physiology; D004172:Diplopia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004576:Electromyography; D005133:Eye Movements / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D015835:Ocular Motility Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D009801:Oculomotor Muscles; D013285:Strabismus / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D014792:Visual Acuity
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A